A patient with a genetic mutation has dysfunctional von Willebrand factor (vWF). Why does this compromise the initial stages of hemostasis in small blood vessel injuries?

💡 Explanation

vWF acts as a bridge between platelets and collagen in the subendothelial matrix, promoting initial platelet adhesion and aggregation. Without functional vWF, the platelet aggregation is impaired at the site of injury because vWF-mediated adhesion is compromised; therefore, the initial hemostatic plug cannot form effectively, rather than thrombin activation or fibrinogen crosslinking being directly affected.

• Why does protein aggregate formation increase in neurons affected by age-related lysosomal dysfunction?
• Why does plaque buildup in arteries increase distal blood pressure variability more than proximal?
• If a patient undergoing anesthesia experiences unexpected bronchospasm and hypotension after propofol administration, which immunological mechanism is most likely causing this patient's anaphylaxis?
• During in vitro fertilization (IVF), which consequence follows when sperm are capacitated prematurely before oocyte retrieval?
• Which process impedes neuronal signal transmission when gap junctions narrow?
• A patient with rheumatoid arthritis takes high-dose aspirin, inhibiting COX-1 and COX-2. Which consequence follows from chronic COX inhibition, impacting prostaglandin-mediated processes?